Items where Author is "Hoess, C."

Article

Alan, M. and Grolimund, E. and Kutz, A. and Christ-Crain, M. and Thomann, R. and Falconnier, C. and Hoess, C. and Henzen, C. and Zimmerli, W. and Mueller, B. and Schuetz, P. and the Pro, Hosp study group. (2015) Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study. Journal of Internal Medicine, 278 (2). pp. 174-184.

Grolimund, E. and Kutz, A. and Marlowe, R. J. and Vogeli, A. and Alan, M. and Christ-Crain, M. and Thomann, R. and Falconnier, C. and Hoess, C. and Henzen, C. and Zimmerli, W. and Mueller, B. and Schuetz, P. and for the Pro, Hosp Study Group. (2015) Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type. Journal of Chronic Obstructive Pulmonary Disease, 12 (3). pp. 295-305.

Schuetz, P. and Friedli, N. and Grolimund, E. and Kutz, A. and Haubitz, S. and Christ-Crain, M. and Thomann, R. and Zimmerli, W. and Hoess, C. and Henzen, C. and Mueller, B. and Pro, Hosp Study Group. (2014) Effect of hyperglycaemia on inflammatory and stress responses and clinical outcome of pneumonia in non-critical-care inpatients: results from an observational cohort study. Diabetologia, 57 (2). pp. 275-284.

Schuetz, P. and Kutz, A. and Grolimund, E. and Haubitz, S. and Demann, D. and Vogeli, A. and Hitz, F. and Christ-Crain, M. and Thomann, R. and Falconnier, C. and Hoess, C. and Henzen, C. and Marlowe, R. J. and Zimmerli, W. and Mueller, B. and Pro, Hosp Study Group. (2014) Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial. International Journal of Cardiology, 175 (3). pp. 464-472.

Zhydkov, A. and Christ-Crain, M. and Thomann, R. and Hoess, C. and Henzen, C. and Zimmerli, W. and Mueller, B. and Schuetz, P.. (2014) Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia. Clinical Chemistry and Laboratory Medicine, 53 (5). pp. 559-566.

Schuetz, P. and Christ-Crain, M. and Wolbers, M. and Schild, U. and Thomann, R. and Falconnier, C. and Widmer, I. and Neidert, S. and Blum, C. A. and Schonenberger, R. and Henzen, C. and Bregenzer, T. and Hoess, C. and Krause, M. and Bucher, H. C. and Zimmerli, W. and Muller, B. and Pro, Hosp study group. (2007) Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Services Research, 7. p. 102.